4G Clinical

4G Clinical is a dynamic company with a meaningful slogan that encapsulates their core mission of accelerating crucial medicines to those in need. Founded in 2015, the company operates in the health care and pharmaceutical industries, with its headquarters in the United States. The company recently received a substantial $230.00M Venture Round investment on 29 June 2021 from Goldman Sachs Asset Management. 4G Clinical aims to expedite clinical research by revolutionizing RTSM (randomization and trial supply management) and supply forecasting capabilities and services. This innovative approach is driven by the company's commitment to aiding sponsors and CROs in following the science as quickly and safely as possible. While not directly involved in discovering novel compounds, 4G Clinical leverages extensive experience and technological innovations to bring speed and agility to clinical trials. The company's solutions, namely Prancer RTSM® and 4C Supply®, endeavor to address the bottlenecks in clinical trials. For individuals and entities interested in exploring these groundbreaking solutions further, more information is available on their website at www.4gclinical.com.